Most studies reported statistically significant reductions in multiple key inflammatory mediators, particularly TNF-α, IL-6, IL-1β, and CRP, which are central to the pathophysiology of insulin resistance, adipose tissue dysfunction, and cardiovascular complications in metabolic syndrome. This evidence concerns the gene IL1B and metabolic syndrome.